Advertisement
Screener

EPIZYME, INC. Patents: Active, 2016

EPIZYME, INC. Active Patents

17 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2016-11-22: Application 15359538; Invention SUBSTITUTED BENZENE COMPOUNDS; Applicant Epizyme, Inc.; Status Patented Case.
  • 2016-11-08: Application 15346677; Invention ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS; Applicant Epizyme, Inc.; Status Patented Case.
  • 2016-09-26: Application 15276324; Invention PRMT1 INHIBITORS AND USES THEREOF; Applicant Epizyme, Inc.; Status Patented Case.
  • 2016-08-26: Application 15248080; Invention COMBINATION THERAPY FOR TREATING CANCER; Applicant Epizyme, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2016-11-2215359538SUBSTITUTED BENZENE COMPOUNDSEpizyme, Inc.Patented Case2018-10-1610098888US20170290837A1
Kevin Wayne Kuntz
John Emmerson Campbell
Masashi Seki
United States
United States
Japan
GEMBEH, SHIRLEY V
2016-11-0815346677ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDSEpizyme, Inc.Patented Case2018-12-1810155002US20170119780A1
Kevin Wayne Kuntz
Richard Chesworth
Kenneth William Duncan
Heike Keilhack
Natalie Warholic
Christine Klaus
Sarah Kathleen Knutson
Timothy James Nelson Wigle
Masashi Seki
Syuji Shirotori
Satoshi Kawano
United States
United States
United States
United States
United States
United States
United States
United States
Japan
Japan
Japan
GEMBEH, SHIRLEY V
2016-09-2615276324PRMT1 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2018-01-169868703US20170233347A1
Kevin Wayne Kuntz
Lorna Helen Mitchell
Gideon Shapiro
Richard Chesworth
Paula Ann Boriack-Sjodin
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2016-08-2615248080COMBINATION THERAPY FOR TREATING CANCEREpizyme, Inc.Patented Case2020-01-0710525074US20170080010A1
Christine Klaus
Maria Alejandra Raimondi
Scott R. Daigle
Roy MacFarlane Pollock
United States
United States
United States
United States
MCINTOSH III, TRAVISS C
2016-08-0815231651PRMT1 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2018-08-0710039748US20170182005A1
Lorna Helen Mitchell
Gideon Shapiro
Richard Chesworth
Paula Ann Boriack-Sjodin
Oscar Miguel Moradei
Kevin Wayne Kuntz
United States
United States
United States
United States
United States
United States
JACKSON, SHAWQUIA
2016-07-1515211792METHOD FOR TREATING CANCEREpizyme, Inc.Patented Case2018-02-139889138US20160346293A1
Heike Keilhack
United States
WEDDINGTON, KEVIN E
2016-06-1015178696ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2018-04-179943504US20170119735A1
Richard Chesworth
Lorna Helen Mitchell
Gideon Shapiro
Kevin Wayne Kuntz
United States
United States
United States
United States
SOLOLA, TAOFIQ A
2016-06-0815177056PRMT5 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2017-10-039777008US20170114061A1
Kenneth W. Duncan
Richard Chesworth
Michael John Munchhof
Lei Jin
United States
United States
United States
United States
REESE, HEIDI L
2016-06-0715176052INHIBITORS OF PROTEIN METHYLTRANSFERASE DOT1L AND METHODS OF USE THEREOFEpizyme, Inc.Patented Case2018-10-3010112968US20170137455A1
Edward J. Olhava
Richard Chesworth
Roy M. Pollock
Lei Jin
United States
United States
United States
United States
LEWIS, PATRICK T
2016-05-2315162384SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDSEpizyme, Inc.Patented Case2019-01-0810174019US20160326170A1
John Emmerson Campbell
Kevin Wayne Kuntz
United States
United States
RAHMANI, NILOOFAR
2016-05-1315036544METHODS FOR TREATING CANCEREPIZYME, INC.Patented Case2018-12-0410143704US20160296548A1
Roy M. Pollock
Scott R. Daigle
Eric Hedrick
Nigel Waters
Blythe Thomson
United States
United States
United States
United States
United States
LAU, JONATHAN S
2016-05-1015150759PRMT5 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2018-12-1110150758US20170088541A1
Kenneth W. Duncan
Richard Chesworth
Michael John Munchhof
United States
United States
United States
BERNHARDT, EMILY A
2016-04-1915132724Inhibitors of Human EZH2, and Methods of Use ThereofEpizyme, Inc.Patented Case2018-04-249949999US20170065628A1
Robert A. Copeland
Victoria M. Richon
Margaret D. Scott
Christopher J. Sneeringer
Kevin W. Kuntz
Sarah K. Knutson
Roy M. Pollock
United States
United States
United States
United States
United States
United States
United States
LEITH, NANCY J
2016-04-0715093103ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2017-08-159732041US20170057926A1
Richard Chesworth
Lorna Helen Mitchell
Gideon Shapiro
Paula Ann Boriack-Sjodin
Oscar Miguel Moradei
Lei Jin
Kenneth W. Duncan
United States
United States
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN
2016-02-2615054193PRMT5 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2017-06-139675614US20170027935A1
Kenneth W. Duncan
Richard Chesworth
Paula Ann Boriack-Sjodin
Michael John Munchhof
Lei Jin
United States
United States
United States
United States
United States
REESE, HEIDI L
2016-01-1314995092PRMT5 INHIBITORS AND USES THEREOFEpizyme, Inc.Patented Case2017-09-199765068US20160368907A1
Kenneth W. Duncan
Richard Chesworth
Paula Ann Boriack-Sjodin
Michael John Munchhof
Lei Jin
United States
United States
United States
United States
United States
REESE, HEIDI L
2016-01-1314904801SUBSTITUTED BENZENE COMPOUNDSEPIZYME, INC.Patented Case2018-12-1110150764US20160194316A1
John Emmerson Campbell
United States
VAJDA, KRISTIN ANN